Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46.2M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
-301K
-
Total reported value, excl. options
-
$214M
-
Value change
-
-$5.53M
-
Put/Call ratio
-
0.96
-
Number of buys
-
30
-
Number of sells
-
-40
-
Price
-
$15.27
Significant Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q2 2021
95 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q2 2021.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 46.2M outstanding shares and own 30.26% of the company stock.
Largest 10 shareholders include MENORA MIVTACHIM HOLDINGS LTD. (2.95M shares), BlackRock Inc. (1.73M shares), WELLINGTON MANAGEMENT GROUP LLP (1.39M shares), CREDIT SUISSE AG/ (1.09M shares), ZEKE CAPITAL ADVISORS, LLC (723K shares), Migdal Insurance & Financial Holdings Ltd. (698K shares), Horton Capital Management, LLC (628K shares), Wildcat Capital Management, LLC (533K shares), Clal Insurance Enterprises Holdings Ltd (529K shares), and STATE STREET CORP (477K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.